McDermott + Bull has successfully placed James Hopper as Senior Director, Business Development at TSTrials. Headquartered in Buenos Aires, Argentina, James will execute TSTrials’ global growth strategy, focused on leading business development, fostering existing partnerships, and developing a robust pipeline of new clinical trials.
James brings a wealth of experience from his recent role as Managing Principal at Techtonic Development Group, where he led business development efforts and key strategic partnerships in health tech innovations. Prior to that, James was the Associate Director of Business Development at Thermo-Fisher Scientific, where he was instrumental in implementing molecular testing in health systems and significantly increasing oncology portfolio revenue. James earned a Masters in Business Administration from Auburn University and a Bachelor of Science in nursing from the University of Alabama Huntsville.
TSTrials is renowned for its expertise in managing large-scale and specialized clinical trials across Latin America, excelling in a diverse array of therapeutic areas, including vaccines and oncology, and bringing speed and efficiency to the process. The organization prides itself on its centralized and decentralized trial management, adherence to international quality standards, and high patient retention rates.
This executive search was completed by McDermott + Bull Partner Jake Vader Zanden, Head of Search Operations Mallory McDermott, Executive Recruiter Adrian Rufo, and Research Associate Michael Mantranga.